✦ LIBER ✦

Inhibition of tumor growth in vivo by hyaluronan oligomers

✍ Scribed by Chunxun Zeng; Bryan P. Toole; Shawn D. Kinney; Jing-wen Kuo; Ivan Stamenkovic

Publisher: John Wiley and Sons
Year: 1998
Tongue: French
Weight: 101 KB
Volume: 77
Category: Article
ISSN: 0020-7136
DOI: 10.1002/(sici)1097-0215(19980729)77:3<396::aid-ijc15>3.0.co;2-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyaluronan-binding peptide can inhibit t

Hyaluronan-binding peptide can inhibit tumor growth by interacting with Bcl-2

✍ Ninfei Liu; Xue-Ming Xu; Jinguo Chen; Luping Wang; Shanmin Yang; Charles B. Unde 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 774 KB

Previous studies have indicated that proteins that bind hyaluronan can also inhibit the growth of tumor cells. To determine if synthetic peptides also possessed these properties, we tested a series of polypeptides containing structural motifs from different proteins for their ability to bind [(3)H]h

PTD4-apoptin protein therapy inhibits tu

PTD4-apoptin protein therapy inhibits tumor growth in vivo

✍ Jun Sun; Ying Yan; Xiao-Ting Wang; Xiao-Wen Liu; Dong-Jun Peng; Min Wang; Jun Ti 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 933 KB

## Abstract Apoptin protein harbors tumor‐selective cell death activity, which makes it a potential anticancer therapy candidate. This study reports an apoptin therapy approach based on protein transduction domain 4 (PTD4)‐mediated transduction of recombinant apoptin protein. __In vitro__, the PTD4

Troglitazone inhibits tumor growth in he

Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo

✍ Jun Yu; Liang Qiao; Lars Zimmermann; Matthias P. A. Ebert; Hongxia Zhang; Wendy 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

Peroxisome proliferator-activated receptor gamma (PPARgamma) has been implicated in the differentiation and growth inhibition of cancer cells. We examined the effects of PPARgamma activation by troglitazone on hepatocellular carcinoma (HCC) cell growth, proliferation, and apoptosis in vitro and in v

In vitro induction of tumor specific imm

In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo

✍ M. Röllinghoff; H. Wagner 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 677 KB

MAZ51, an indolinone that inhibits endot

MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth in vitro, suppresses tumor growth in vivo

✍ Vladimir Kirkin; Wilko Thiele; Petra Baumann; Ralph Mazitschek; Katrin Rohde; Gu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 400 KB 👁 1 views

## Abstract We have recently described MAZ51, an indolinone that blocks the ligand‐induced autophosphorylation of VEGFR‐3, a receptor tyrosine kinase that plays a central role in the regulation of lymphangiogenesis. Here we show that MAZ51 is able to block the proliferation of VEGFR‐3‐expressing hu

Inhibition of human tumor cell growth in

Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228

✍ Grégoire P. Prevost; Anne Pradines; Marie-Christine Brezak; Marie-Odile Lonchamp 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 100 KB 👁 2 views

Oncogenic mutations of the ras gene leading to constitutive activation of downstream effectors have been detected in a wide spectrum of human cancers (pancreas, thyroid, colon, non-small-cell lung cancer). Membrane anchorage of Ras, required for functional activity in signal transduction, is facilit